Summit Therapeutics PLC says c-difficile trial slowed by coronavirusBy FinMar NewsAugust 16, 2023US infectious diseases agency BARDA is helping to fund the trial with a grant worth up to $72.5mln. (NASDAQ:SMMT) said it had recruited 252 patients into…
